Molecular determinants and signaling effects of PKA RIalpha phase separation
Tirzepatide does not carry the same degree of resting heart rate elevation signal observed with retatrutide
Microdosing GLP-1s began emerging as a trend after Wegovy, an Ozempic competitor, was approved by the FDA for obesity in 2021
We make it easy At Fridays, our solutions are simple, effective, and accessible
By engaging all three, it impacts several overlapping hormonal systems involved in metabolism, appetite, and energy balance
The overall market size is expected to grow by 8X during the same period, supported by expanding treatment eligibility, increasing public reimbursement coverage, and growing clinical evidence for cardiovascular risk reduction benefits